The effects of remifentanil anesthesia on glucose control in diabetic patients undergoing coronary artery bypass graft surgery

The effects of remifentanil anesthesia on glucose control in diabetic patients undergoing coronary artery bypass graft surgery - Remifentanil anesthesia on glucose control in diabetic patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016053

Enrollment

Registered

2014-12-25

Start date

2012-06-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic patients undergoing coronary artery bypass graft surgery

Interventions

fentanyl-propofol based anesthesia for coronary artery bypass graft surgery remifentanil-propofol based anesthesia for coronary artery bypass graft surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetic patients undergoing off-pump coronary artery bypass graft surgery

Exclusion criteria

Exclusion criteria: Emergency surgeries hemodialysis patients The patient whom insulin, adrenalin, and steroid was used for in anesthesia

Design outcomes

Primary

Measure	Time frame
the levels of glucose in the blood the levels of adrenaline in the blood the levels of noradrenaline in the blood the levels of cortisol in the blood the levels of insuline in the blood	—

Countries

Japan

Contacts

Public ContactHirotoshi Kitagawa

Shiga university of medical science Department of anesthesiology

hirotosi@belle.shiga-med.ac.jp077-548-2281

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026